Revolutions Medical Corp (RMCP) Financial Statements (2025 and earlier)
Company Profile
Business Address |
1124 PARK WEST BLVD MOUNT PLEASANT, SC 29466 |
State of Incorp. | NV |
Fiscal Year End | December 31 |
Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
9/30/2014 MRQ | 12/31/2013 | 12/31/2012 | |||
---|---|---|---|---|---|
ASSETS | |||||
Current Assets | |||||
Cash, cash equivalents, and short-term investments | 1 | 0 | |||
Cash and cash equivalents | 1 | 0 | |||
Inventory, net of allowances, customer advances and progress billings | 279 | 322 | |||
Inventory | 279 | 322 | |||
Prepaid expense | 3 | ✕ | |||
Prepaid expense and other current assets | ✕ | ✕ | 5 | ||
Total current assets: | 282 | 327 | |||
Noncurrent Assets | |||||
Property, plant and equipment | 270 | 357 | |||
Intangible assets, net (including goodwill) | 134 | 107 | |||
Intangible assets, net (excluding goodwill) | 134 | 107 | |||
Total noncurrent assets: | 404 | 463 | |||
TOTAL ASSETS: | 686 | 790 | |||
LIABILITIES AND EQUITY | |||||
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities, including: | 1,867 | 1,122 | |||
Other undisclosed accounts payable and accrued liabilities | 1,867 | 1,122 | |||
Debt | 495 | 184 | |||
Derivative instruments and hedges, liabilities | 658 | 365 | |||
Deferred revenue and credits | 73 | ||||
Total current liabilities: | 3,094 | 1,671 | |||
Noncurrent Liabilities | |||||
Other undisclosed liabilities | 4,831 | 2,735 | |||
Total liabilities: | 7,924 | 4,407 | |||
Equity | |||||
Equity, attributable to parent, including: | (7,238) | (3,617) | |||
Preferred stock | 1 | 1 | |||
Common stock | 107 | 73 | |||
Additional paid in capital | 37,088 | 34,319 | |||
Other undisclosed equity, attributable to parent | (44,434) | (38,010) | |||
Total equity: | (7,238) | (3,617) | |||
TOTAL LIABILITIES AND EQUITY: | 686 | 790 |
Income Statement (P&L) ($ in thousands)
9/30/2014 TTM | 12/31/2013 | 12/31/2012 | ||
---|---|---|---|---|
Revenues | 41 | 1 | ||
Cost of revenue | (20) | (9) | ||
Cost of goods and services sold | (1,985) | (793) | ||
Other undisclosed gross profit | (1,965) | (784) | ||
Gross profit: | (1,944) | (792) | ||
Operating expenses | (3,898) | (5,063) | ||
Operating loss: | (5,842) | (5,854) | ||
Nonoperating expense | (582) | (1,310) | ||
Debt instrument, convertible, beneficial conversion feature | 171 | 238 | ||
Other nonoperating income (expense) | (1) | 273 | ||
Interest and debt expense | (886) | (1,714) | ||
Loss from continuing operations: | (7,311) | (8,879) | ||
Loss before gain (loss) on sale of properties: | (7,311) | (8,879) | ||
Other undisclosed net income | 886 | 1,714 | ||
Net loss available to common stockholders, basic: | (6,425) | (7,164) | ||
Interest on convertible debt | (200) | |||
Net loss available to common stockholders, diluted: | (6,625) | (7,164) |
Comprehensive Income ($ in thousands)
9/30/2014 TTM | 12/31/2013 | 12/31/2012 | ||
---|---|---|---|---|
Net loss: | (6,425) | (7,164) | ||
Comprehensive loss, net of tax, attributable to parent: | (6,425) | (7,164) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.